BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  StrideBio Announces Mark Velleca, M.D., Ph.D., as Chief Executive Officer

  StrideBio, Inc. today announced the appointment of industry veteran Mark Velleca, M.D., Ph.D. as Chief Executive Officer and a member of its Board of Directors.

  February 4, 2022

   · 

  3 min read
• Deals

  AVROBIO Announces Today Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  AVROBIO, Inc. today announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 167,000 shares of the company’s common stock to three new employees as inducement awards under the company’s 2019 Inducement Plan.

  February 4, 2022

   · 

  6 min read
• Business

  Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors

  Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors.

  February 4, 2022

   · 

  7 min read
• Bio NC

  Labcorp Launches Labcorp OnDemand Digital Health Platform

  Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Labcorp OnDemand, an easy experience where individuals can purchase Labcop OnDemand tests online.

  February 4, 2022

   · 

  4 min read
• Policy

  StageZero Life Sciences Announces Warrant Extension

  StageZero Life Sciences, Ltd. announces that it has applied to the Toronto Stock Exchange to extend the expiry date of 5,702,314.00 outstanding common share purchase warrants (the “Warrants”) to January 31, 2023.

  February 4, 2022

   · 

  4 min read
• MedMira Provides a Pre-Annual General Meeting Update

  Today, MedMira Inc. (MedMira) (TSXV: MIR) provides a pre-Annual General Meeting (AGM) update on its regulatory and product development progress.

  February 4, 2022

   · 

  5 min read
• Business

  Surgery Partners, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call Details

  Surgery Partners, Inc. announced the Company will release its fourth quarter 2021 results after market close on Monday, February 28, 2022, to be followed by a conference call at 5:00 p.m. (Eastern Time).

  February 4, 2022

   · 

  1 min read
• Biotech Bay

  Cytokinetics Announces FDA Acceptance of New Drug Application for Omecamtiv Mecarbil for the Treatment of Heart Failure With Reduced Ejection Fraction

  Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) has accepted and filed the company’s New Drug Application (NDA) for omecamtiv mecarbil.

  February 4, 2022

   · 

  6 min read
• Business

  Twist Bioscience Reports First Quarter 2022 Financial Results

  Twist Bioscience Corporation today reported financial results and business highlights for the first quarter of fiscal 2022 ended December 31, 2021.

  February 4, 2022

   · 

  11 min read
• Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets

  Evotec SE announces today that the Company has been informed by Bayer about a decision to discontinue the development of the investigational P2X3 receptor antagonist eliapixant (BAY1817080), which stems from a former Evotec/Bayer multi-target research alliance.

  February 4, 2022

   · 

  1 min read